A. Nadel

发表

The multinational Men's Attitudes to Life Events and Sexuality (MALES) study: I. Prevalence oSf erectile dysfunction and related health concerns in the general population

C. Niederberger, W. Fisher, M. Sand, 2004, Current medical research and opinion.

Relationship between baseline hepatic status and outcome, and effect of sorafenib on liver function: SHARP trial subanalyses.

V. Mazzaferro, J. Bruix, M. Sherman, 2012, Journal of hepatology.

Long-term safety of sorafenib in advanced renal cell carcinoma: follow-up of patients from phase III TARGET.

C. Porta, J. Bellmunt, C. Szczylik, 2010, European journal of cancer.

Platelet transfusions during coronary artery bypass graft surgery are associated with serious adverse outcomes

S. Body, B. Spiess, J. Murkin, 2004, Transfusion.

Analyses of coronary graft patency after aprotinin use: results from the International Multicenter Aprotinin Graft Patency Experience (IMAGE) trial.

B. Chaitman, H. Schaff, E. Alderman, 1998, The Journal of thoracic and cardiovascular surgery.

Frequency of early occlusion and stenosis in a left internal mammary artery to left anterior descending artery bypass graft after surgery through a median sternotomy on conventional bypass: benchmark for minimally invasive direct coronary artery bypass.

H. Schaff, P. Berger, E. Alderman, 1999, Circulation.

Vardenafil improved patient satisfaction with erectile hardness, orgasmic function and sexual experience in men with erectile dysfunction following nerve sparing radical prostatectomy.

M. Thibonnier, G. Brock, A. Nadel, 2005, The Journal of urology.

The multinational Men's Attitudes to Life Events and Sexuality (MALES) Study Phase II: understanding PDE5 inhibitor treatment seeking patterns, among men with erectile dysfunction.

C. Niederberger, W. Fisher, M. Sand, 2004, The journal of sexual medicine.

Efficacy and safety of sorafenib in patients with alcohol-related hepatocellular carcinoma: A sub-analysis from the SHARP trial

C. Porta, J. Bruix, J. Llovet, 2008 .

67 EFFICACY AND SAFETY OF SORAFENIB IN PATIENTS WITH HEPATOCELLULAR CARCINOMA (HCC): SUBANALYSIS OF SHARP TRIAL BASED ON BARCELONA CLINIC LIVER CANCER (BCLC) STAGE

J. Bruix, M. Sherman, J. Llovet, 2009 .

Effects of age and gender on the pharmacokinetics of the soluble guanylate cyclase stimulator riociguat

J. Lettieri, A. Nadel, W. Mück, 2013, BMC Pharmacology and Toxicology.

Forging Unity out of Many - is Jewish Peoplehood the New Way Forward for the American Jewish Community? Investigating Jewish Peoplehood as a Motivating Agenda in and beyond American Jewish Institutions

A. Nadel, 2013 .

Efficacy of Metrifonate in Improving the Psychiatric and Behavioral Disturbances of Patients with Alzheimer's Disease

J. Cummings, A. Nadel, Donna Masterman, 2001, Journal of geriatric psychiatry and neurology.

Cost analysis of aprotinin for coronary artery bypass patients: analysis of the randomized trials.

S. Datta, L. Muhlbaier, G. Samsa, 2004, The Annals of thoracic surgery.

Full-Dose Aprotinin Use in Coronary Artery Bypass Graft Surgery: An Analysis of Perioperative Pharmacotherapy and Patient Outcomes

S. Body, B. Spiess, J. Murkin, 2006, Anesthesia and analgesia.

Efficacy and safety of sorafenib in patients with advanced hepatocellular carcinoma and vascular invasion or extrahepatic spread: A subanalysis from the SHARP trial

D. Amadori, V. Mazzaferro, J. Bruix, 2008 .

Efficacy and safety of sorafenib in patients with advanced hepatocellular carcinoma according to ECOG performance status: A subanalysis from the SHARP trial

J. Marrero, J. Bruix, J. Llovet, 2008 .

Efficacy and safety of sorafenib in patients with advanced hepatocellular carcinoma: subanalyses of a phase III trial.

C. Porta, V. Mazzaferro, J. Marrero, 2012, Journal of hepatology.

Rivaroxaban: a novel oral anticoagulant for the prevention and treatment of several thrombosis‐mediated conditions

C. Nessel, S. Berkowitz, Guohua Pan, 2013, Annals of the New York Academy of Sciences.

The multinational Men's Attitudes to Life Events and Sexuality study: the influence of diabetes on self‐reported erectile function, attitudes and treatment‐seeking patterns in men with erectile dysfunction

C. Niederberger, M. Sand, R. Rosen, 2007, International journal of clinical practice.

Metrifonate treatment of AD

B. Gulanski, A. Brashear, A. Nadel, 1999, Neurology.

Effects of age and gender on the pharmacokinetics of the soluble guanylate cyclase stimulator riociguat

J. Lettieri, A. Nadel, W. Mück, 2013, BMC Pharmacology and Toxicology.

994 EFFICACY AND SAFETY OF SORAFENIB IN PATIENTS WITH ADVANCED HEPATOCELLULAR CARCINOMA AND PRIOR ANTI-TUMOR THERAPY: A SUBANALYSIS FROM THE SHARP TRIAL

J. Marrero, J. Bruix, P. Galle, 2008 .

A multicenter, double-blind, placebo-controlled trial of aprotinin for reducing blood loss and the requirement for donor-blood transfusion in patients undergoing repeat coronary artery bypass grafting.

R. E. Clark, H. Schaff, B. Spiess, 1995, Circulation.